Founders Capital Management (Connecticut)’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $249K | Hold |
3,184
| – | – | 0.04% | 75 |
|
|
2026
Q1 | $276K | Sell |
3,184
-4,325
| -58% | -$414K | 0.05% | 67 |
|
|
2025
Q4 | $721K | Buy |
7,509
+78
| +1% | +$7.58K | 0.11% | 51 |
|
|
2025
Q3 | $708K | Hold |
7,431
| – | – | 0.11% | 50 |
|
|
2025
Q2 | $648K | Hold |
7,431
| – | – | 0.11% | 52 |
|
|
2025
Q1 | $668K | Hold |
7,431
| – | – | 0.12% | 51 |
|
|
2024
Q4 | $594K | Buy |
7,431
+15
| +0.2% | +$1.3K | 0.1% | 54 |
|
|
2024
Q3 | $668K | Buy |
7,416
+100
| +1% | +$8.41K | 0.12% | 50 |
|
|
2024
Q2 | $576K | Sell |
7,316
-122
| -2% | -$10K | 0.1% | 54 |
|
|
2024
Q1 | $648K | Sell |
7,438
-600
| -7% | -$51.2K | 0.12% | 52 |
|
|
2023
Q4 | $662K | Sell |
8,038
-138
| -2% | -$10.5K | 0.14% | 51 |
|
|
2023
Q3 | $641K | Hold |
8,176
| – | – | 0.15% | 50 |
|
|
2023
Q2 | $720K | Sell |
8,176
-3,748
| -31% | -$323K | 0.16% | 50 |
|
|
2023
Q1 | $961K | Hold |
11,924
| – | – | 0.24% | 43 |
|
|
2022
Q4 | $927K | Hold |
11,924
| – | – | 0.25% | 44 |
|
|
2022
Q3 | $963K | Hold |
11,924
| – | – | 0.27% | 42 |
|
|
2022
Q2 | $1.07M | Buy |
11,924
+65
| +0.5% | +$6.59K | 0.27% | 41 |
|
|
2022
Q1 | $1.32M | Hold |
11,859
| – | – | 0.28% | 40 |
|
|
2021
Q4 | $1.23M | Hold |
11,859
| – | – | 0.27% | 38 |
|
|
2021
Q3 | $1.49M | Hold |
11,859
| – | – | 0.38% | 36 |
|
|
2021
Q2 | $1.47M | Sell |
11,859
-370
| -3% | -$46.5K | 0.36% | 40 |
|
|
2021
Q1 | $1.45M | Buy |
12,229
+370
| +3% | +$43.4K | 0.36% | 41 |
|
|
2020
Q4 | $1.39M | Hold |
11,859
| – | – | 0.4% | 40 |
|
|
2020
Q3 | $1.23M | Sell |
11,859
-3,720
| -24% | -$374K | 0.39% | 39 |
|
|
2020
Q2 | $1.43M | Hold |
15,579
| – | – | 0.49% | 36 |
|
|
2020
Q1 | $1.41M | Sell |
15,579
-12
| -0.1% | -$1.28K | 0.56% | 34 |
|
|
2019
Q4 | $1.77M | Hold |
15,591
| – | – | 0.58% | 32 |
|
|
2019
Q3 | $1.69M | Hold |
15,591
| – | – | 0.6% | 31 |
|
|
2019
Q2 | $1.52M | Buy |
15,591
+600
| +4% | +$54.8K | 0.54% | 31 |
|
|
2019
Q1 | $1.36M | Sell |
14,991
-46,584
| -76% | -$4.17M | 0.5% | 32 |
|
|
2018
Q4 | $5.6M | Sell |
61,575
-7,972
| -11% | -$745K | 2.4% | 17 |
|
|
2018
Q3 | $6.69M | Sell |
69,547
-442
| -0.6% | -$40.9K | 2.73% | 15 |
|
|
2018
Q2 | $5.99M | Sell |
69,989
-760
| -1% | -$63.5K | 2.73% | 16 |
|
|
2018
Q1 | $5.48M | Buy |
70,749
+600
| +0.9% | +$49.5K | 2.52% | 19 |
|
|
2017
Q4 | $5.67M | Buy |
70,149
+340
| +0.5% | +$27.2K | 2.51% | 19 |
|
|
2017
Q3 | $5.43M | Sell |
69,809
-480
| -0.7% | -$39.9K | 2.58% | 19 |
|
|
2017
Q2 | $6.2M | Hold |
70,289
| – | – | 3.09% | 15 |
|
|
2017
Q1 | $5.66M | Buy |
70,289
+100
| +0.1% | +$7.81K | 2.89% | 18 |
|
|
2016
Q4 | $5M | Sell |
70,189
-675
| -1% | -$53K | 2.71% | 18 |
|
|
2016
Q3 | $6.12M | Hold |
70,864
| – | – | 3.42% | 11 |
|
|
2016
Q2 | $6.15M | Sell |
70,864
-2,286
| -3% | -$185K | 3.46% | 12 |
|
|
2016
Q1 | $5.49M | Sell |
73,150
-1,606
| -2% | -$121K | 3.19% | 15 |
|
|
2015
Q4 | $5.75M | Sell |
74,756
-3,468
| -4% | -$261K | 3.46% | 10 |
|
|
2015
Q3 | $5.24M | Sell |
78,224
-6,059
| -7% | -$446K | 3.38% | 14 |
|
|
2015
Q2 | $6.25M | Sell |
84,283
-551
| -0.6% | -$42.1K | 3.75% | 8 |
|
|
2015
Q1 | $6.62M | Sell |
84,834
-345
| -0.4% | -$26.1K | 3.96% | 8 |
|
|
2014
Q4 | $6.15M | Buy |
85,179
+1,997
| +2% | +$139K | 3.76% | 8 |
|
|
2014
Q3 | $5.15M | Buy |
83,182
+1,717
| +2% | +$109K | 3.3% | 13 |
|
|
2014
Q2 | $5.19M | Buy |
81,465
+5,056
| +7% | +$307K | 3.44% | 13 |
|
|
2014
Q1 | $4.7M | Buy |
76,409
+321
| +0.4% | +$18.7K | 3.77% | 11 |
|
|
2013
Q4 | $4.37M | Buy |
+76,088
| New | +$4.31M | 3.68% | 11 |
|
Other funds holding MDT
Founders Capital Management (Connecticut)'s MDT Position: Q2 2026 in Review
Founders Capital Management (Connecticut) held its Medtronic (MDT) position steady in Q2 2026 at 3,184 shares worth $249K. The position accounts for 0.04% of the portfolio, ranked #75.
Founders Capital Management (Connecticut) first reported a position in MDT in Q4 2013 and has held it in 51 quarters since. The position peaked at $6.69M in Q3 2018. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Founders Capital Management (Connecticut) held 3,184 shares of Medtronic worth $249K as of Q2 2026.
- Founders Capital Management (Connecticut) left its Medtronic share count unchanged in Q2 2026.
- Medtronic made up 0.04% of Founders Capital Management (Connecticut)'s portfolio in Q2 2026, its #75 holding.
- Founders Capital Management (Connecticut) first reported a position in Medtronic in Q4 2013 and has held it in 51 quarters since.
- Founders Capital Management (Connecticut)'s Medtronic position peaked at $6.69M in Q3 2018.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Founders Capital Management (Connecticut)'s 13F filing for Q2 2026, filed 20 Jul 2026.